FdaApplication
ANDA 203291
Identifiers
- fda_app_no: ANDA203291
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2017-07-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE; ETHINYL ESTRADIOL | 3MG;0.02MG | TABLET;ORAL |
1 product